NCT03796494

Brief Summary

This is a randomized, single-blind, split-mouth clinical trial to evaluate the performance of peri-implant tissues (bone and soft tissues) in conventionally loaded Galimplant implants, using a classic multi-position, anti-rotational abutment, comparing it to the new multi-abutment aesthetic slim anti-rotational placed both at the time of the implant surgery. To this end, 80 Galimplant implants with a diameter of 4 mm and 10 mm in length will be placed in areas of mature scarred post-extraction bone. Patients be divided into 2 study groups, group C: straight pillar; Group T: Slim pillar. The bone and clinical radiological stability of the peri-implant tissues will be evaluated at 6 weeks post-surgery and at 6-12-24 months post-prosthetic loading.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 3, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 8, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2020

Completed
Last Updated

December 2, 2024

Status Verified

March 1, 2020

Enrollment Period

1 month

First QC Date

January 3, 2019

Last Update Submit

November 26, 2024

Conditions

Keywords

dental implantperiimplant tissues

Outcome Measures

Primary Outcomes (1)

  • Primary stability of implants and peri-implant tissues

    Randomly and following the inclusion and exclusion criteria, the implants will be placed with the normal preparation protocol. Investigators will evaluate the immediate post-surgical stability of implants and peri-implant tissues through the Ostell system, based on the resonance frequency analysis (RFA). The implant stability quotient (ISQ) is the value on a scale that indicates the level of stability and osseointegration in dental implants. The scale ranges from 1 to 100, with higher values indicating greater stability. The acceptable stability range lies between 55-85 ISQ

    10 months

Secondary Outcomes (6)

  • Basal Peri-implant tissue level: implant stability

    1 day

  • Basal Radiological Bone Implant level

    1 day

  • Basal Peri-implant tissue level: probing depth

    1 day

  • Radiological bone implant stability

    8 weeks

  • Peri-implant tissue stability: probing depth

    8 weeks

  • +1 more secondary outcomes

Other Outcomes (6)

  • 6-months clinical evaluation of probing depth

    6 months

  • 6-months ISQ evaluation

    6 months

  • 6-months radiological evaluation of definitive prostheses

    6 months

  • +3 more other outcomes

Study Arms (2)

Control Group

ACTIVE COMPARATOR

The control group is considered, using the company's classic multi-position straight anti-rotational abutment

Procedure: Straight abutment

Test group

EXPERIMENTAL

The test group is considered, where the new multi-position straight esthetic anti-rotational slim abutment is used

Procedure: Slim abutment

Interventions

This is the classic abutment, straight and anti-rotational for dental implants which have been tested before

Control Group
Slim abutmentPROCEDURE

This is the new concept of the prostheses abutment, slim and anti-rotational to improve the width of biologic space

Test group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients without systemic pathology that are grounds for absolute contraindication
  • Older adults who agree to be part of the study and sign the informed consent
  • Consumption of tobacco less than 5 cigarettes / day
  • Do not be completely toothless
  • Absences of at least two pieces in posterior area with or without free ends to distal, maxillary or mandibular that do not require regenerative techniques. In case of odd absences (3,5,7), a Slim pillar will be placed, being the group to always be the majority.
  • Area of mature bone healed at least 6 months post-extraction.
  • Patients with a sufficient amount of bone to place implants 4 mm in diameter and 10 mm long

You may not qualify if:

  • Immunosuppressed
  • Aesthetic edentulous areas of 13-23 and 33-43
  • Smokers of more than 5 cigarettes
  • Index of bleeding greater than 30%
  • Patients with less than 2 mm of keratinized gingiva
  • Implants with primary stability with ISQ \<55
  • Implants with ISQ index \<55 at 8 weeks
  • When a margin of safety can not be assumed to the inferior dental nerve of at least 1 mm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mario Pérez Sayáns

Santiago de Compostela, A Coruña, 15785, Spain

Location

Related Links

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Mario Perez Sayans MD, PhD (Principal investigator)

Study Record Dates

First Submitted

January 3, 2019

First Posted

January 8, 2019

Study Start

March 1, 2019

Primary Completion

April 1, 2019

Study Completion

January 8, 2020

Last Updated

December 2, 2024

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will share

We will anonymize and categorize the clinical and radiological data of the patients to share the information with the other researchers of the group

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
Time Frame:
Access Criteria
under request

Locations